R&D News | pharmaphorum

News

Is Merck planning a $30bn-plus move for Seagen?

Speculation that Merck & Co may be preparing a $30 billion takeover bid for Seagen – bolstering its oncology ambitions – has the biopharma community aflutter.

News

Pharmacy chain Walgreens plans to disrupt clinical trial sec...

Walgreens is the latest US retail pharmacy giant to have a go at disrupting the clinical trials industry, with the launch of a new business unit that will tap into its reserve of patient da

News

Decentralised trials gaining ground in oncology, says report

A survey of clinical research executives working in the cancer arena has found that nearly three quarters of them will include decentralised designs in trials due to start in the next 12 mo

News

Biogen waves bye to $217m ALS partnership with Karyopharm

Biogen has ducked out of a four-year-old collaboration with Karyopharm on a drug candidate for the neurodegenerative disease amyotrophic lateral sclerosis that could have been worth up to $

News

Reitsberger Hof Originalbild unter: http://xaver.fotograf.de/photo/5803d868-7d30-46c9-9bef-33690a5581f6

MorphoSys slims down, narrowing its focus to cancer

MorphoSys seemingly inexorable shift into an oncology pure-play has continued with an out-licensing deal for two programmes in the kidney disease and immunology categories to HIBio.

News

Closeup of X-ray photography of human brain

Another amyloid miss in Alzheimer's as Roche's crenezumab fa...

The litany of failed trials of amyloid-targeting drugs for Alzheimer's disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline

Is Merck planning a $30bn-plus move for Seagen?

Pharmacy chain Walgreens plans to disrupt clinical trial sec...

Decentralised trials gaining ground in oncology, says report

Biogen waves bye to $217m ALS partnership with Karyopharm

MorphoSys slims down, narrowing its focus to cancer

Another amyloid miss in Alzheimer's as Roche's crenezumab fa...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks